Last $0.51 USD
Change Today +0.0221 / 4.51%
Volume 1.9M
CYTX On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 5:20 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Marc H. Hedrick M.D.

Chief Executive Officer, President and Director, Cytori Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 board members in 1 different organizations across 2 different industries.

See Board Relationships
51$961,629
As of Fiscal Year 2013

Background*

Dr. Marc H. Hedrick, MD has been the President of Cytori Therapeutics, Inc. (also known as Macropore Biosurgery Inc.) since June 23, 2004 and has been its Chief Executive Officer since April 2, 2014. Dr. Hedrick served as Principal Financial Officer of Cytori Therapeutics, Inc. since August 2014. Dr. Hedrick joined Cytori Therapeutics, Inc. as the Chief Scientific Officer and Medical Director in October 2002. He co-founded StemSource Inc. and served as the Chief Executive ...

Read Full Background

Corporate Headquarters*

3020 Callan Road
San Diego, California 92121

United States

Phone: 858-458-0900
Fax: 858-458-0994

Board Members Memberships*

2002-Present
Chief Executive Officer, President and Director

Education*

MD
University of Texas Southwestern Medical Center - Dallas
MBA
UCLA Anderson School of Management

Other Affiliations*

Annual Compensation*

Salary$406,627
Total Annual Compensation$406,627

Stock Options*

Exercisable Options638,644
Unexercisable Options291,356
Total Number of Options930,000

Total Compensation*

Total Annual Cash Compensation$495,760
Total Short Term Compensation$406,627
Total Calculated Compensation$961,629
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYTX:US $0.51 USD +0.0221

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Robin C. Stracey Interim Chief Executive Officer, Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Governance & Nominating Committee
Cesca Therapeutics Inc.
--
Martin M. McGlynn Chief Executive Officer, President, Director, Member of Strategic Transactions Committee, Chief Executive Officer of StemCells California Inc and President of StemCells California Inc
StemCells Inc.
$835.8K
Martin P. Rosendale Chief Executive Officer and Director
Nuo Therapeutics, Inc.
$467.3K
Bernard A. Hausen M.D., Ph.D.Co-Founder, Chief Executive Officer, President, Chief Medical Officer, Director and Member of Strategic Review Committee
Cardica Inc.
$455.8K
Andrey Semechkin Ph.D.Co-Chairman and Chief Executive Officer
International Stem Cell Corporation
$258.5K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYTORI THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.